Thirty years ago most patients with type 2 diabetes did not develop the disease until they were in their late 60’s. They often did not develop the cardiovascular or kidney problems that we are so worried about today. This was likely due to their advanced age at diagnosis and a shorter lifespan in general. As the onset age of type 2 diabetes has become younger in the last three decades we have seen a marked increase in CVD, and we treat these patients more aggressively than ever.
We also look at our type 1 patients differently and have figured out that early and aggressive glucose control will reduce later in life complications. But what about aggressively treating one of the major causes of CVD, hypertension?
For years the guidelines we followed were 140/90, but this week our intern, Maya Rudolph, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate, makes a strong case for targeting 120/80 in these younger patients.